These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5742816)

  • 1. [Antifibrinolytic activity of the blood in rheumatic patients].
    Panchenko VM; Pastorova VE
    Vopr Revm; 1968; 8(2):85-7. PubMed ID: 5742816
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of aspirin on the blood coagulation system of rheumatic children].
    Briazgunov IP
    Vopr Okhr Materin Det; 1966 Nov; 11(11):61-5. PubMed ID: 5996732
    [No Abstract]   [Full Text] [Related]  

  • 3. [The inhibitors of fibrinolysis].
    Badimón L; Villaverde CA; Bastida E; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1978 Apr; 4(1):98-9. PubMed ID: 697408
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the influence of protease inhibitors and synthetic antifibrinolytic agents on the bleeding time].
    Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):174-8. PubMed ID: 4174655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemocoagulation and fibrinolytic activity of the blood in patients with rheumatism treated with prednisolone].
    Krutovskaia OV
    Vopr Revm; 1969; 9(4):36-8. PubMed ID: 5379812
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of prednisolone and salicylates on the fibrinolytic activity of the blood of rheumatic patients].
    Ionov IU
    Ter Arkh; 1966 Feb; 38(2):34-7. PubMed ID: 5988265
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemostatic activity of certain antifibrinolytics in hemorrhagic diathesis mainly caused by thrombocytopenia].
    Gembitskiĭ EV; Larchenko GK
    Klin Med (Mosk); 1975 May; 53(5):58-65. PubMed ID: 1152391
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative studies on the fibrinolysis inhibitors AMCHA, epsilon-ACA and PAMBA].
    Fischer M
    Wien Z Inn Med; 1966 Apr; 47(4):143-53. PubMed ID: 6005160
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of para-aminomethylbenzoic acid on the fibrinolytic activity in different tissues].
    Merkulov MF; Maliugina IB
    Farmakol Toksikol; 1968; 31(5):605-7. PubMed ID: 5707737
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative action of prednisolone, triamcinolone and dexamethasone on hemostatic function in rheumatic patients].
    Mit'kin AF; Bochkareva LE
    Ter Arkh; 1968 Sep; 40(9):38-40. PubMed ID: 5739671
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peripheral vascular system in rheumatic fever in children].
    Ordyński J
    Pol Tyg Lek; 1971 May; 26(18):661-4. PubMed ID: 4326262
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of fibrinolysis activators and inhibitors in the complex treatment of patients with acute pneumonia].
    Sheleg VA
    Vrach Delo; 1986 Jun; (6):47-8. PubMed ID: 3750958
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antifibrinolytic and coagulation inhibiting effect of Contrykal].
    Schulz K; Gülzow M
    Dtsch Gesundheitsw; 1969 Jun; 24(23):1057-60. PubMed ID: 5393838
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic and preventive action of combined use of anti-rheumatic agents and health resort factors in diseases of the joints].
    Iasinovskiĭ MA; Leshchinskiĭ AF
    Ter Arkh; 1968 Jan; 40(1):3-11. PubMed ID: 5747053
    [No Abstract]   [Full Text] [Related]  

  • 17. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems of fibrinolysis in extracorporeal circulation. Clinical and experimental research].
    Ghilardi F; Del Fante FM; Indrio MG; Marchisio O
    Minerva Anestesiol; 1966 Oct; 32(10):577-84. PubMed ID: 5994090
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Dec; 108(12):727-60 passimf. PubMed ID: 4911753
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunochemical study of fibrinogen disintegration products in the blood serum of patients with rheumatism].
    Trubnikov GA; Balashov VI; Tatarinov IuS; Ragozin IuE; Podobedov GM
    Ter Arkh; 1973 Jan; 45(1):23-7. PubMed ID: 4203678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.